Cargando…
The demethylase inhibitor GSK-J4 limits inflammatory colitis by promoting de novo synthesis of retinoic acid in dendritic cells
Dendritic cells (DCs) promote T-cell mediated tolerance to self-antigens and induce inflammation to innocuous-antigens. This dual potential makes DCs fundamental players in inflammatory disorders. Evidence from inflammatory colitis mouse models and inflammatory bowel diseases (IBD) patients indicate...
Autores principales: | Doñas, Cristian, Neira, Jocelyn, Osorio-Barrios, Francisco, Carrasco, Macarena, Fernández, Dominique, Prado, Carolina, Loyola, Alejandra, Pacheco, Rodrigo, Rosemblatt, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809056/ https://www.ncbi.nlm.nih.gov/pubmed/33446666 http://dx.doi.org/10.1038/s41598-020-79122-3 |
Ejemplares similares
-
Trichostatin A Promotes the Generation and Suppressive Functions of Regulatory T Cells
por: Doñas, Cristian, et al.
Publicado: (2013) -
The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells
por: Sui, Aixia, et al.
Publicado: (2017) -
Retinoic Acid as a Modulator of T Cell Immunity
por: Bono, Maria Rosa, et al.
Publicado: (2016) -
The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
por: Wang, Jing-Jing, et al.
Publicado: (2022) -
Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
por: Li, Yunan, et al.
Publicado: (2018)